Fosun Pharma to buy 100m doses of BioNTech's Covid-19 vaccine for mainland China


Source: straitstimes.com straitstimes.com

Key Topics in this News Article:

News Snapshot:

BEIJING (REUTERS) - Chinese drugmaker Shanghai Fosun Pharmaceutical Group on Wednesday (Dec 16) said it will buy at least 100 million doses of a Covid-19 vaccine from Germany's BioNTech for use in mainland China next year, if the vaccine receives approval. The Chinese government has not announced supply deals with Western drugmakers, which instead have partnered local firms. Fosun said it will be entitled to 60 per cent of annual gross profit from sales of doses that it will make from imported bulk ingredients, and 65 per cent of profit from sales of doses imported ready for use. For the...